• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Medinol Ltd

Medinol has first human implant of drug-eluting peripheral stent in Australia

October 7, 2024 By Sean Whooley

Medinol today announced the successful first-in-human implantation of its ChampioNIR drug-eluting peripheral stent. Dr. Gerard S. Goh and Dr. Thodur Vasudevan of the Alfred Hospital in Melbourne, Australia, completed the stent implant. The company says it introduces a “revolutionary advancement” in the mechanics, durability and drug delivery of peripheral drug-eluting stents. Tel Aviv, Israel-based Medinol […]

Filed Under: Drug-Device Combinations, Implants, Stents, Vascular Tagged With: Medinol Ltd, nitinol

Medinol stent performs just as well as Medtronic Resolute, study says

January 6, 2020 By Chris Newmarker

The EluNIR drug-eluting stent made by Medinol performed just as well as the Resolute Integrity or Resolute Onyx stents from Medtronic (NYSE:MDT), according to new clinical study results from an international team of researchers. The randomized clinical trial — conducted by researchers from the U.S., Israel, Canada and the Netherlands — involved 2,221 people and compared […]

Filed Under: Cardiovascular, Drug-Device Combinations, Drug-Eluting Stents, Featured, News Well, Stents Tagged With: Cardinal Health, Medinol Ltd, Medtronic

US Court of Appeals revives Medinol stent suit against Cordis

April 23, 2018 By Fink Densford

The US Court of Appeals for the Federal Circuit this week revived a stent patent infringement suit brought by Medinol against Cordis and its former parent company Johnson & Johnson (NYSE:JNJ). The suit, originally filed in 2013, claimed that Cordis infringed on Medinol stent patents filed between 1999 and 2005. The case was vacated in 2014 […]

Filed Under: Legal News, Patent Infringement, Stents Tagged With: Cordis Corp., Medinol Ltd

Cordis, Medinol tout first commercial implants of Elunir drug-eluting stent in U.S.

January 11, 2018 By Sarah Faulkner

Cordis and Medinol announced today that the first commercial uses of the Elunir drug-eluting stent in the U.S. were performed at New York-Presbyterian Hospital/Columbia University Medical Center and the Piedmont Heart Institute in Atlanta. The Elunir stent, developed by Medinol and distributed by Cordis, features a metallic spring tip and the narrowest strut width of any stent on […]

Filed Under: Drug-Device Combinations, Drug-Eluting Stents, Implants, Pharmaceutical, Wall Street Beat Tagged With: Cordis Corp., Medinol Ltd

Cordis, Medinol win FDA nod for Elunir drug-eluting stent

November 30, 2017 By Sarah Faulkner

Cordis and Medinol announced today that the FDA approved its Elunir drug-eluting stent for the treatment of patients with narrowing or blocked coronary arteries. The stent, designed by Medinol and distributed exclusively by Cordis in the U.S., features a novel metallic spring tip and the narrowest strut width of any stent on the market in the U.S., according […]

Filed Under: Drug-Device Combinations, Drug-Eluting Stents, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance, Vascular Tagged With: Cordis Corp., Medinol Ltd

Cordis inks exclusive distribution deal for Medinol’s coronary stent portfolio in US

October 30, 2017 By Sarah Faulkner

Cordis has inked an exclusive distribution deal to sell Medinol‘s coronary stents in the U.S., the company reported, adding a cobalt-chromium bare-metal stent and a drug-eluting stent to its portfolio. According to the deal, Cordis plans to start selling Medinol’s NIRxcell BMS immediately and will exclusively distribute the company’s EluNir drug-eluting stent if it wins FDA approval. […]

Filed Under: Cardiovascular, Drug-Device Combinations, Drug-Eluting Stents, Pharmaceutical, Stents, Vascular Tagged With: Cordis Corp., Medinol Ltd

Medinol wins CE Mark for EluNir drug-eluting coronary stent system

October 26, 2017 By Sarah Faulkner

Medinol said today that it won CE Mark clearance for its EluNir drug-eluting stent – a device designed with a low metal footprint and a elastomeric coating. In one 958-patient clinical study, the coronary stent had a 12-month target lesion failure rate of 5.4% and a 0% rate of late stent thrombosis, proving non-inferior to the […]

Filed Under: Drug-Device Combinations, Pharmaceutical, Regulatory/Compliance, Vascular, Wall Street Beat Tagged With: Medinol Ltd

Supreme Court remands medical device patent cases

March 28, 2017 By Sarah Faulkner

The U.S. Supreme Court sent back several appeals to the federal circuit this week, including 1 relating to Johnson & Johnson‘s (NYSE:JNJ) stent patent fight with Medinol, in light of a recent vote regarding the use of laches in patent infringement cases. Defendants use laches to declare that a plaintiff unreasonably delayed in bringing a claim […]

Filed Under: Legal News, Stents, Wall Street Beat Tagged With: Johnson and Johnson, Medinol Ltd

Japan OKs Medinol stent trial

November 8, 2016 By Brad Perriello

Medinol said yesterday that Japanese regulators approved a clinical trial of its Elunir drug-eluting stent that it plans to add to an ongoing U.S. trial of the device. The thin-strut, ridaforolimus-eluting Elunir stent (previously known as Bionir) features an elastomeric coating that’s designed to be more flexible than prior-generation polymer coatings. Last month, Medinol presented 1-year […]

Filed Under: Cardiovascular, Clinical Trials, Drug-Eluting Stents Tagged With: Medinol Ltd

EuroPCR 2016 Update: TAVR innovations, FFR systems in the spotlight

May 18, 2016 By Fink Densford

UPDATED May 20, 2016, with more results out of Paris. St. Jude Medical (NYSE:STJ) announced it won CE Mark approval in the European Union for its PressureWire X Guidewire fractional flow reserve measurement system and is launching the product in Europe. The company announced the launch and clearance at the EuroPCR meeting in Paris this week. […]

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Drug-Eluting Stents, Replacement Heart Valves, Stent Grafts, Stents Tagged With: Biotronik, Edwards Lifesciences, EuroPCR 2016, InspireMD, Leerink Partners, Medinol Ltd, Reva Medical Inc., stjudemedical

Medinol launches trial for NIRxcell stent

March 21, 2016 By Brad Perriello

Medinol said it enrolled the 1st U.S. patient in a post-market study of its bare-metal NIRxcell stent, which has been on the U.S. market since January 2015. Tel Aviv-based Medinol said the NIRxcell stent is a 5th-generation stent using its WiZeCell design and the Flexx2 spring-tip delivery catheter. The device 1st won pre-market approval from the FDA in December […]

Filed Under: Clinical Trials, Stents Tagged With: Medinol Ltd

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy